US Patent Issued to Lieber Institute on Feb. 25 for "Pyridine carboxamide compounds for inhibiting NAV1.8" (Maryland, Delaware Inventors)

ALEXANDRIA, Va., Feb. 26 -- United States Patent no. 12,234,221, issued on Feb. 25, was assigned to Lieber Institute Inc. (Baltimore).

"Pyridine carboxamide compounds for inhibiting NAV1.8" was invented by Michael Poslusney (Owings Mills, Md.), Glen Ernst (Bear, Del.), James Barrow (Arnold, Md.) and Yifang Huang (Baltimore).

According to the abstract* released by the U.S. Patent & Trademark Office: "Pyridine carboxamide compounds for inhibiting NaV1.8 and methods for treating a condition, disease, or disorder associated with an increased NaV1.8 activity or expression are disclosed."

The patent was filed on July 9, 2019, under Application No. 17/256,781.

*For further information, including images, charts and tables, please visit: http://...